- Phase 3 topline data from azetukalner FOS epilepsy program planned for H2 2025 in support of NDA filing and potential commercial launch - First of three planned Phase 3 azetukalner MDD studies ...

Dr. Waltzman’s panel, titled “Ensuring Effective and Efficient Trials Through Clinical Operations” will be Monday, April 7 th from 4:05PM – 4:35PM ET.

Meet Sterimove, the innovative mobile robot designed for Grade A/B/C/D cleanrooms, optimizing pharmaceutical production while ...

Pharmaceutical Refrigerator MED-125 from Kirsch Pharmaceutical Refrigerator MED-85 from Kirsch High Credibility: This website adheres to all nine standards of credibility and transparency.

Tonix Pharmaceuticals (TNXP) announced it has been awarded a grant from the Medical CBRN Defense Consortium, MCDC, to support the development of TNX-801. MCDC is a consortium of industrial ...

PhaseV, a leader in AI/ML-driven clinical development, announced today that it will demonstrate new capabilities of its platform for clinical trials at the upcoming Chief Medical Officer (CMO) Summit ...

Bipolar disorder is characterized by extreme mood swings, bouts of mania or hypomania, and episodes of depression. It is a ...

The widening gap in expectations between early career hires and organizations, combined with an increased awareness of the ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...

With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other ...

Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...

DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the evolving Metabolic Dysfunction-Associated Steatohepatitis (MASH) market ...